Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline 2023-08-25 19:37
Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth 2023-08-25 19:26
Tigermed Reports 2023 Interim Results 2023-08-25 18:39
Zhiyi Biotech Announced First Subject Dosed in the U.S. Phase 1 clinical Trial of SK10, in Development for Treatment of Chemotherapy-induced Diarrhea 2023-08-25 18:19
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 2023-08-25 15:14
AsiaMedic Sets New Standard in Healthcare with Installation of First SIGNA™ Hero 3.0T MRI Scanner in Asia-Pacific 2023-08-25 14:12
3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced 2023-08-25 10:06
Everest Medicines Announces New Drug Application Acceptance by the Pharmaceutical Administration Bureau of Macao for Nefecon® for the Treatment of Primary IgA Nephropathy 2023-08-25 08:15
Antheia Achieves Major Commercial Milestone 2023-08-25 08:01
Laekna, Inc. (2105.HK) Announces Interim Results 2023 2023-08-25 08:00
YS Biopharma Announces Purchase of Shares by Company Officers 2023-08-25 04:15
Ping An Health announces 2023 interim results 2023-08-24 20:58
Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA 2023-08-24 20:00
Vittra APS Unique composite by FGM is appointed as a solution to a clinical problem by the renowned agency Dental Advisor 2023-08-24 18:00
111, Inc. Announces Second Quarter 2023 Unaudited Financial Results 2023-08-24 14:00
MRI Software's first 'Voice of the Strata Manager' report reveals unseen pressures of high-demand real estate industry job 2023-08-24 13:02
PeptiGrowth Inc. and Orizuru Therapeutics, Inc. Enter into Joint Development of Novel Synthetic Peptide Based Growth Factor 2023-08-24 09:51
Everest Medicines Announces Interim Results for First Half of 2023 2023-08-24 08:15
Samsung Biologics appoints new leadership to oversee quality and regulatory affairs 2023-08-24 07:59
Salvia BioElectronics: First-Ever Patient Treated with Breakthrough Neuromodulation Solution for Severe Migraine and Cluster Headache in Australia 2023-08-24 05:45
1 162 163 164 165 166 970